Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.

Pharmaceutical

Cipla

Umang Vohra

Deepak Viegas

Vijayasarathi Ramaswami

Raju Mistry

Ashish Musaddi

The Legal and Compliance team at Cipla is responsible for ensuring that the company adheres to all applicable laws and regulations across its global operations. This team provides legal guidance on mergers and acquisitions, manages compliance frameworks, and oversees regulatory matters related to pharmaceutical manufacturing and distribution. Additionally, they play a crucial role in risk management and safeguarding the company's interests in various therapeutic areas and geographical markets.

Legal and Compliance

Market Access and Pricing

Regulatory Affairs and Quality Management

Legal and Compliance

About

Team members

Other teams at Cipla

Market Access and Pricing

Regulatory Affairs and Quality Management